Multiple Choice
Cell-free deoxyribonucleic acid (cfDNA) screening is a new method of noninvasive prenatal testing (NIPT) that has recently become available in the clinical setting.This technology can provide a definitive diagnosis of which findings? (Select all that apply. )
A) Fetal Rh status
B) Fetal gender
C) Maternally transmitted gene disorder
D) Paternally transmitted gene disorder
E) Trisomy 21
Correct Answer:

Verified
Correct Answer:
Verified
Q2: Which assessments are included in the fetal
Q3: A woman is undergoing a nipple-stimulated contraction
Q4: A 41-week pregnant multigravida arrives at the
Q5: Biophysical risks include factors that originate with
Q6: Which analysis of maternal serum may predict
Q8: A pregnant woman's biophysical profile (BPP)score is
Q9: How does the nurse document a non-stress
Q10: While working with the pregnant client in
Q11: Biophysical risks include factors that originate with
Q12: The indirect Coombs' test is a screening